组学关联研究中筛选固定数量特征的两阶段分析
针对组学关联研究需将特征集缩小至固定数量以供验证的场景,提出两阶段筛选方法:第一阶段以宽松的FDR水平初筛,再从中选取统计显著性最高的一部分特征;对剩余特征集仅依据生物学考虑选取,从而可评估最终固定大小特征集的FDR水平。基于参数模型的模拟实验和真实微阵列数据集显示,与标准筛选方法相比,该方法在生物学考虑下筛选出的特征数量大幅增加。
要点
- 两阶段法控制的是最终固定大小验证特征集的FDR,而非初筛特征集的FDR。
- 第一阶段以宽松FDR水平初筛,再选取统计显著性最高的一部分特征。
- 剩余特征仅依据生物学考虑选取,模拟和真实数据中筛选特征数较标准方法大幅增加。
核心结论
- 提出的两阶段筛选方法可控制最终固定大小特征集的FDR,并提高筛选功效。
研究设计与样本
- 方法学研究,提出两阶段筛选方法,并通过基于参数模型的模拟实验和真实微阵列数据集进行验证。
主要发现
- 基于参数模型的模拟实验和真实微阵列数据集显示,与标准筛选方法相比,所提方法在生物学考虑下筛选出的特征数量大幅增加。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
One of main roles of omics-based association studies with high-throughput technologies is to screen out relevant molecular features, such as genetic variants, genes, and proteins, from a large pool of such candidate features based on their associations with the phenotype of interest. Typically, screened features are subject to validation studies using more established or conventional assays, where the number of evaluable features is relatively limited, so that there may exist a fixed number of features measurable by these assays. Such a limitation necessitates narrowing a feature set down to a fixed size, following an initial screening analysis via multiple testing where adjustment for multiplicity is made. We propose a two-stage screening approach to control the false discovery rate (FDR) for a feature set with fixed size that is subject to validation studies, rather than for a feature set from the initial screening analysis. Out of the feature set selected in the first stage with a relaxed FDR level, a fraction of features with most statistical significance is firstly selected. For the remaining feature set, features are selected based on biological consideration only, without regard to any statistical information, which allows evaluating the FDR level for the finally selected feature set with fixed size. Improvement of the power is discussed in the proposed two-stage screening approach. Simulation experiments based on parametric models and real microarray datasets demonstrated substantial increment in the number of screened features for biological consideration compared with the standard screening approach, allowing for more extensive and in-depth biological investigations in omics association studies.
引用
- Kawabata T, Emoto R, Nishino J, et al. Two-stage analysis for selecting fixed numbers of features in omics association studies. Stat Med. 2019. PMID: 30931544. doi:10.1002/sim.8150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。